article thumbnail

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. A broader range of novel dosage forms can be developed for the patients, and even individualized manufacturing, without extensive alterations to the process. billion US in 2021 to $1.9